ANIP - ANI PHARMACEUTICALS INC

QQQ $ 455.25 $ 5.77 (1.29 %)

DIA $ 409.08 $ 4.58 (1.13 %)

SPY $ 546.60 $ 6.05 (1.12 %)

TLT $ 99.96 $ 0.43 (0.43 %)

GLD $ 231.58 $ 0.97 (0.42 %)

Previous Close

$ 58.48

Open

Bid

$ 58.47 x 200

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 48.20 - $ 70.81

Volume

529,404

Average Volume

Market Cap

1.23B

Beta (5Y Monthly)

$ 0.83

PE Ratio (TTM)

$ 48.46

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2024	06-30-2024	10-Q
2	05-10-2024	03-31-2024	10-Q
3	02-29-2024	12-31-2023	10-K
4	11-08-2023	09-30-2023	10-Q
5	08-09-2023	06-30-2023	10-Q
6	05-08-2023	03-31-2023	10-Q
7	03-09-2023	12-31-2022	10-K
8	11-09-2022	09-30-2022	10-Q
9	08-08-2022	06-30-2022	10-Q
10	05-10-2022	03-31-2022	10-Q
11	03-15-2022	12-31-2021	10-K
12	11-01-2021	09-30-2021	10-Q
13	08-06-2021	06-30-2021	10-Q
14	05-07-2021	03-31-2021	10-Q
15	03-11-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-06-2020	06-30-2020	10-Q
18	05-07-2020	03-31-2020	10-Q
19	02-27-2020	12-31-2019	10-K
20	11-06-2019	09-30-2019	10-Q
21	08-07-2019	06-30-2019	10-Q
22	05-09-2019	03-31-2019	10-Q
23	02-27-2019	12-31-2018	10-K
24	11-06-2018	09-30-2018	10-Q
25	08-07-2018	06-30-2018	10-Q
26	05-08-2018	03-31-2018	10-Q
27	02-27-2018	12-31-2017	10-K
28	11-02-2017	09-30-2017	10-Q
29	08-03-2017	06-30-2017	10-Q
30	05-04-2017	03-31-2017	10-Q
31	03-02-2017	12-31-2016	10-K
32	11-03-2016	09-30-2016	10-Q
33	08-04-2016	06-30-2016	10-Q
34	05-05-2016	03-31-2016	10-Q
35	02-23-2016	12-31-2015	10-K
36	11-03-2015	09-30-2015	10-Q
37	08-04-2015	06-30-2015	10-Q
38	05-05-2015	03-31-2015	10-Q
39	02-23-2015	12-31-2014	10-K
40	11-10-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on ANI ...
08/07/2024 12:19:31

HC Wainwright & Co. analyst Oren Livnat reiterates ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and maintains $94 price ...

ANI Pharmaceuticals Announced Its Intentio...
08/07/2024 11:14:44

ANI Pharmaceuticals Forecasts 2024 Adjuste...
08/06/2024 11:03:05

Revised Full Year 2024 Guidance:The following guidance for 2024 does not include contribution from the pending acquisition of A...

ANI Pharmaceuticals Forecasts 2024 Net Rev...
08/06/2024 11:01:15

ANI Pharmaceuticals Q2 2024 Adj. EPS $1.02...
08/06/2024 10:51:30

ANI's Generic L-Glutamine Oral Powder Hits...
07/15/2024 11:05:00

ANI Pharmaceuticals, Inc. (ANI or the Company) (NASDAQ:ANIP) today announced that following final approval from the U.S. Food a...

ANI Pharmaceuticals Announces FDA Approval...
07/02/2024 11:03:31

NVIDIA To Rally Around 19%? Here Are 10 To...
06/26/2024 12:12:59

HC Wainwright & Co. Maintains Buy on ANI P...
06/26/2024 10:43:52

HC Wainwright & Co. analyst Oren Livnat maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and raises the price targ...

nasdaq-records-worst-session-since-april-with-nvidia-plunging-7-dow-jones-sees-modest-gains-amid-mixed-market-close

Nasdaq Records Worst Session Since April W...
06/25/2024 06:45:26

generics-player-ani-pharmaceuticals-strengthens-rare-disease-segment-with-380m-alimera-sciences-deal

Generics Player ANI Pharmaceuticals Streng...
06/24/2024 15:28:28

ANI Pharmaceuticals to acquire Alimera Sciences for $5.50 per share in cash, plus a contingent value right of up to $0.50 per s...

ANI Pharma to Snap Alimera Sciences Valuin...
06/24/2024 10:55:27

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) ("ANI" or the "Company") and Alimera Sciences, Inc. (NASDAQ:ALIM) ("...

ANI Pharmaceuticals Has Launched Kionex (S...
05/20/2024 10:52:47

U.S. annual sales for Sodium Polystyrene Sulfonate Oral / Rectal Suspension total approximately $30.3 million, based on March 2...

HC Wainwright & Co. Maintains Buy on ANI P...
05/13/2024 15:03:46

HC Wainwright & Co. analyst Oren Livnat maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and raises the price targ...

ANI Pharmaceuticals Reiterates FY24 Outloo...
05/10/2024 10:59:28

ANI continues to expect total company adjusted non-GAAP gross margin between 62% and 63% and the Company will continue to tax e...

ANI Pharmaceuticals Q1 Adj $1.21 Beats $1....
05/10/2024 10:55:13

ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $...

Evaluating ANI Pharmaceuticals: Insights F...
04/23/2024 18:00:36

Guggenheim Reiterates Buy on ANI Pharmaceu...
04/23/2024 16:55:06

Guggenheim analyst Vamil Divan reiterates ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and maintains $77 price target.

ANI Pharmaceuticals Announces The Launch O...
04/09/2024 10:51:13

U.S. annual sales for Baclofen Oral Suspension total approximately $39 million, according to IQVIA data.

ANI Pharmaceuticals Announces the Launch o...
03/27/2024 10:51:50

ANI Pharmaceuticals, Inc. (ANI or the Company) (NASDAQ:ANIP) today announced the launch of Levofloxacin Oral Solution, a generi...